Wyeth launches “ambush” at start of Effexor trial, court told
Intellectual Property 2018-06-04 10:13 pm | Sydney
Pharmaceutical giant Wyeth’s has launched an “ambush” at the beginning of a trial after a nine-year long battle against several generic drug makers, alleging infringement of a second patent for its blockbuster Effexor-XR, a judge heard Monday.
For information on rights and reprints, contact subscriptions@lawyerly.com.au